Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Extramembranous Glomerulopathy

fluorodeoxyglucose f18 has been researched along with Extramembranous Glomerulopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bos, WJ; Grutters, JC; van Moorsel, CH; van Velzen-Blad, H; Verwoerd, A; Vorselaars, AD1
Feng, Z; Huang, Y; Liang, X; Shi, W; Wang, S; Zhang, B1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Extramembranous Glomerulopathy

ArticleYear
Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency.
    The European respiratory journal, 2015, Volume: 46, Issue:1

    Topics: Biomarkers; Diabetic Nephropathies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Heart Failure; Humans; Male; Middle Aged; Nephrotic Syndrome; Pilot Projects; Positron-Emission Tomography; Receptors, Interleukin-2; Regression Analysis; Renal Insufficiency; Retrospective Studies; Sarcoidosis

2015
A follow-up analysis of positron emission tomography/computed tomography in detecting hidden malignancies at the time of diagnosis of membranous nephropathy.
    Oncotarget, 2016, Mar-01, Volume: 7, Issue:9

    Topics: Adult; Aged; Cohort Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proteinuria; Retrospective Studies

2016